Greenwich LifeSciences, Inc. Stock Analysis & AI Score
Greenwich LifeSciences, Inc. (GLSI) has an ST Score of 36.6 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $50.00 price target (+176.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Greenwich LifeSciences, Inc. (GLSI) has an ST Score of 36.6 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $50.00 price target (+176.2% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- ValuationB-
- Financial StrengthC
- MomentumC
- GrowthD+
- ProfitabilityF
- Piotroski1/9
Contact
GLSI stock: frequently asked questions
What is GLSI's ST Score?
Greenwich LifeSciences, Inc. (GLSI) has an ST Score of 36.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GLSI a buy, hold, or sell?
Analysts rate GLSI a Buy, with a price target of $50.00 (+176.2% vs the current price). Our ST Score grades it C (36.6/100). The ST Score is a data-driven signal, not a recommendation.
What are GLSI's factor grades?
Valuation B-, Profitability F, Financial Strength C, Momentum C, Growth D+, Forecast A.
What is GLSI's valuation grade?
Greenwich LifeSciences, Inc. (GLSI) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GLSI's growth grade?
Greenwich LifeSciences, Inc. (GLSI) earns a growth grade of D+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GLSI's profitability grade?
Greenwich LifeSciences, Inc. (GLSI) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GLSI's financial strength grade?
Greenwich LifeSciences, Inc. (GLSI) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GLSI?
The average analyst price target for Greenwich LifeSciences, Inc. (GLSI) is $50.00 from 2 analysts, which is +176.2% versus the recent price of $18.10.
What is GLSI's Piotroski score?
Greenwich LifeSciences, Inc. (GLSI) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.